Variation_Name | GeneID | GeneSymbol | ClinicalSignificance | dbSNP | RCVaccession | TestedInGTR | PhenotypeIDs | Chromosome | Start | Stop | HGVS_c | HGVS_p | HGVS_g | OtherIDs | Disease_ClinVar | Disease_hgmd | NM_000168.5(GLI3):c.3481C>T (p.Gln1161Ter) | 2737 | GLI3 | Pathogenic | 116840770 | RCV000031884; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42005190 | 42005190 | NM_000168.5:c.3481C>T | NP_000159.3:p.Gln1161Ter | NC_000007.13:g.42005190G>A | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.3456G>T (p.Glu1152Asp) | 2737 | GLI3 | Pathogenic | 116840769 | RCV000031883; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42005215 | 42005215 | NM_000168.5:c.3456G>T | NP_000159.3:p.Glu1152Asp | NC_000007.13:g.42005215C>A | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.3439G>T (p.Glu1147Ter) | 2737 | GLI3 | Pathogenic | 116840768 | RCV000014829; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42005232 | 42005232 | NM_000168.5:c.3439G>T | NP_000159.3:p.Glu1147Ter | NC_000007.13:g.42005232C>A | OMIM Allelic Variant:165240.0006 | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.3386_3387delTT (p.Phe1129Terfs) | 2737 | GLI3 | Pathogenic | 281864935 | RCV000031882; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42005284 | 42005285 | NM_000168.5:c.3386_3387delTT | NP_000159.3:p.Phe1129Terfs | NC_000007.13:g.42005284_42005285delAA | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.3324C>G (p.Tyr1108Ter) | 2737 | GLI3 | Pathogenic | 116840766 | RCV000031881; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42005347 | 42005347 | NM_000168.5:c.3324C>G | NP_000159.3:p.Tyr1108Ter | NC_000007.13:g.42005347G>C | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.3004delG (p.Val1002Terfs) | 2737 | GLI3 | Pathogenic | 116840765 | RCV000031880; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42005667 | 42005667 | NM_000168.5:c.3004delG | NP_000159.3:p.Val1002Terfs | NC_000007.13:g.42005667delC | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2935delT (p.Cys979Alafs) | 2737 | GLI3 | Pathogenic | 116840764 | RCV000031879; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42005736 | 42005736 | NM_000168.5:c.2935delT | NP_000159.3:p.Cys979Alafs | NC_000007.13:g.42005736delA | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2799C>G (p.Tyr933Ter) | 2737 | GLI3 | Pathogenic | 116840763 | RCV000031878; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42005872 | 42005872 | NM_000168.5:c.2799C>G | NP_000159.3:p.Tyr933Ter | NC_000007.13:g.42005872G>C | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2770_2771insNC_012920.1:g.12243..12314 | 2737 | GLI3 | Pathogenic | -1 | RCV000014834; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42005900 | 42005901 | NM_000168.5:c.2770_2771insNC_012920.1:g.12243..12314 | | | OMIM Allelic Variant:165240.0011,dbVar:nssv3761571,dbVar:nsv1067831 | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2628delC (p.Ser877Alafs) | 2737 | GLI3 | Pathogenic | 116840762 | RCV000031877; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42006043 | 42006043 | NM_000168.5:c.2628delC | NP_000159.3:p.Ser877Alafs | NC_000007.13:g.42006043delG | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2620delC (p.Arg874Alafs) | 2737 | GLI3 | Pathogenic | 116840761 | RCV000031876; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42006051 | 42006051 | NM_000168.5:c.2620delC | NP_000159.3:p.Arg874Alafs | NC_000007.13:g.42006051delG | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2567C>A (p.Ser856Ter) | 2737 | GLI3 | Pathogenic | 116840760 | RCV000031875; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42006104 | 42006104 | NM_000168.5:c.2567C>A | NP_000159.3:p.Ser856Ter | NC_000007.13:g.42006104G>T | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2483delC (p.Pro828Argfs) | 2737 | GLI3 | Pathogenic | 116840759 | RCV000031874; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42006188 | 42006188 | NM_000168.5:c.2483delC | NP_000159.3:p.Pro828Argfs | NC_000007.13:g.42006188delG | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2431+1G>A | 2737 | GLI3 | Pathogenic | 116840758 | RCV000031873; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42007193 | 42007193 | NM_000168.5:c.2431+1G>A | | NC_000007.13:g.42007193C>T | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2346_2356delGCTAAAACAAG (p.Arg782Serfs) | 2737 | GLI3 | Pathogenic | 116840756 | RCV000031871; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42007269 | 42007279 | NM_000168.5:c.2346_2356delGCTAAAACAAG | NP_000159.3:p.Arg782Serfs | NC_000007.13:g.42007269_42007279delCTTGTTTTAGC | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2351_2355delAACAA (p.Lys784Serfs) | 2737 | GLI3 | Pathogenic | 116840757 | RCV000031872; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42007270 | 42007274 | NM_000168.5:c.2351_2355delAACAA | NP_000159.3:p.Lys784Serfs | NC_000007.13:g.42007270_42007274delTTGTT | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2188_2206del19 (p.Leu730Valfs) | 2737 | GLI3 | Pathogenic | 116840754 | RCV000014841; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42007419 | 42007437 | NM_000168.5:c.2188_2206del19 | NP_000159.3:p.Leu730Valfs | NC_000007.13:g.42007419_42007437del19 | OMIM Allelic Variant:165240.0017 | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2197_2198delAC (p.Thr733Argfs) | 2737 | GLI3 | Pathogenic | 116840755 | RCV000031870; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42007427 | 42007428 | NM_000168.5:c.2197_2198delAC | NP_000159.3:p.Thr733Argfs | NC_000007.13:g.42007427_42007428delGT | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2172dupC (p.Asn725Glnfs) | 2737 | GLI3 | Pathogenic | 116840753 | RCV000031869; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42007453 | 42007453 | NM_000168.5:c.2172dupC | NP_000159.3:p.Asn725Glnfs | NC_000007.13:g.42007453dupG | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2157delC (p.Ile720Serfs) | 2737 | GLI3 | Pathogenic | 116840752 | RCV000031868; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42007468 | 42007468 | NM_000168.5:c.2157delC | NP_000159.3:p.Ile720Serfs | NC_000007.13:g.42007468delG | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2149C>T (p.Gln717Ter) | 2737 | GLI3 | Pathogenic | 116840751 | RCV000031867; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42007476 | 42007476 | NM_000168.5:c.2149C>T | NP_000159.3:p.Gln717Ter | NC_000007.13:g.42007476G>A | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2146C>T (p.Gln716Ter) | 2737 | GLI3 | Pathogenic | 116840750 | RCV000031866; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42007479 | 42007479 | NM_000168.5:c.2146C>T | NP_000159.3:p.Gln716Ter | NC_000007.13:g.42007479G>A | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2139delC (p.Cys713Terfs) | 2737 | GLI3 | Pathogenic | 116840749 | RCV000031865; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42007486 | 42007486 | NM_000168.5:c.2139delC | NP_000159.3:p.Cys713Terfs | NC_000007.13:g.42007486delG | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2110C>T (p.Gln704Ter) | 2737 | GLI3 | Pathogenic | 116840748 | RCV000031864; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42007515 | 42007515 | NM_000168.5:c.2110C>T | NP_000159.3:p.Gln704Ter | NC_000007.13:g.42007515G>A | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2062G>T (p.Glu688Ter) | 2737 | GLI3 | Pathogenic | 116840747 | RCV000031863; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42011977 | 42011977 | NM_000168.5:c.2062G>T | NP_000159.3:p.Glu688Ter | NC_000007.13:g.42011977C>A | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2058_2059delGGinsAT (p.Glu687Ter) | 2737 | GLI3 | Pathogenic | 116840746 | RCV000031862; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42011980 | 42011981 | NM_000168.5:c.2058_2059delGGinsAT | NP_000159.3:p.Glu687Ter | NC_000007.13:g.42011980_42011981delCCinsAT | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2032delG (p.Asp678Thrfs) | 2737 | GLI3 | Pathogenic | 116840745 | RCV000031861; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42012007 | 42012007 | NM_000168.5:c.2032delG | NP_000159.3:p.Asp678Thrfs | NC_000007.13:g.42012007delC | - | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2023delG (p.Glu675Serfs) | 2737 | GLI3 | Pathogenic | 116840744 | RCV000014825; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42012016 | 42012016 | NM_000168.5:c.2023delG | NP_000159.3:p.Glu675Serfs | NC_000007.13:g.42012016delC | OMIM Allelic Variant:165240.0002 | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.2012delG (p.Gly671Glufs) | 2737 | GLI3 | Pathogenic | 116840743 | RCV000014826; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42012027 | 42012027 | NM_000168.5:c.2012delG | NP_000159.3:p.Gly671Glufs | NC_000007.13:g.42012027delC | OMIM Allelic Variant:165240.0003 | C0265220 146510 Pallister-Hall syndrome | | |
NM_000168.5(GLI3):c.1998_2001delCCGA (p.Pro668Leufs) | 2737 | GLI3 | Pathogenic | 116840742 | RCV000031860; | N | MedGen:C0265220,OMIM:146510,ORPHA:672,SNOMED CT:56677004 | 7 | 42012038 | 42012041 | NM_000168.5:c.1998_2001delCCGA | NP_000159.3:p.Pro668Leufs | NC_000007.13:g.42012038_42012041delTCGG | - | C0265220 146510 Pallister-Hall syndrome | | |